Sanofi India appoints Deepak Arora as MD
Arora brings over 30 years of experience in the pharmaceutical and healthcare industry
Arora brings over 30 years of experience in the pharmaceutical and healthcare industry
Anil Gupta has been appointed as the Senior Vice President, and Sanjay Singhania has taken charge as the Vice President of PHDCCI
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME
Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Subscribe To Our Newsletter & Stay Updated